Tech Company Financing Transactions

NovaDigm Therapeutics Funding Round

NovaDigm Therapeutics, operating out of Brookline, raised $10 million in funding from private investors.

Transaction Overview

Announced On
2/21/2013
Transaction Type
Venture Equity
Amount
$10,002,358
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.

Company Information

Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1622A Beacon St. 302
Brookline, MA 02446
USA
Email Address
Overview
NovaDigm Therapeutics is a biomedical firm developing vaccines and therapeutics for the treatment of infections.
Profile
NovaDigm Therapeutics LinkedIn Company Profile
Social Media
NovaDigm Therapeutics Company Twitter Account
Company News
NovaDigm Therapeutics News
Facebook
NovaDigm Therapeutics on Facebook
YouTube
NovaDigm Therapeutics on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Timothy Cooke
  Timothy Cooke LinkedIn Profile  Timothy Cooke Twitter Account  Timothy Cooke News  Timothy Cooke on Facebook
Chief Scientific Officer
John Hennessey
  John Hennessey LinkedIn Profile  John Hennessey Twitter Account  John Hennessey News  John Hennessey on Facebook
VP - Bus. Development
Tuomas Holmberg
  Tuomas Holmberg LinkedIn Profile  Tuomas Holmberg Twitter Account  Tuomas Holmberg News  Tuomas Holmberg on Facebook


 

 

Browse more venture capital transactions:

Prev: 2/21/2013: Clustrix venture capital transaction
Next: 2/21/2013: Balanced venture capital transaction

 

Share this article

 


About Our Venture Capital Transactions Database

We report on every notable VC transaction. All VC database entries on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary